Double Patenting

7 articles available

Forxiga (dapagliflozin), developed by BMS/AstraZeneca, is now making room for generics to squeeze in. In Russia, this process has been dramatically accelerated: the latest court case has ruled that…

The 2026 AIPPI World Congress, held in Hamburg from 7 to 10 October, brought together IP practitioners, judges, industry representatives and academics from around the world. Its patent programme…

A divisional is worth what it allows its owner to argue later. G 1/25, and the referral now pending as G 1/26, sharpen a familiar point: that value comes from the choices made at filing and during…

The use of divisional patent applications in order to ensure flexibility and to keep a patentee’s options open as to the protection it seeks to obtain is established practice in many patent offices…

The Brazilian Patent Statute (Law #9,279/96) does not explicitly prohibit double patenting per se.  However, as shown in the statistics set out below, the BRPTO regularly considers double patenting. …

On 6 January 2023, the Danish Maritime and Commercial High Court dismissed an application for remission to the Board of Appeal of the registration of a utility model. The court considered whether…

In Immunex Corp. et al. v. Sandoz Inc. et al., the Federal Circuit found that there was no obviousness-type double patenting because there was no “common ownership” of patents under an agreement…